Read + Share
Amedeo Smart
Independent Medical Education
Tanzi E, Di Modica SM, Bordini J, Olivari V, et al. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in beta-thalassemic mice. Am J Hematol 2024;99:1313-1325.PMID: 38629683
Email
LinkedIn
Privacy Policy